KRAS G12C is the most common KRAS pathogenic variant, occurring in 40–50% of NSCLC cases, and is a critical oncogenic driver found in ~13% of all lung adenocarcinomas [17]. Here, KRAS is linked to non-small cell lung carcinoma.